Banque Cantonale Vaudoise’s Teva Pharmaceuticals TEVA Stock Holding History

Banque Cantonale Vaudoise’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123	Sell	3,627 -1,506	-29%	-$50.2K	﹤0.01%	688
2026 Q1	$155K	Hold	5,133	–	–	0.01%	669
2025 Q4	$160K	Buy	5,133 +306	+6%	+$7.54K	0.01%	586
2025 Q3	$98K	Buy	4,827 +23	+0.5%	+$404	﹤0.01%	620
2025 Q2	$81K	Hold	4,804	–	–	﹤0.01%	612
2025 Q1	$74K	Buy	+4,804	New	+$85.8K	﹤0.01%	656
2024 Q3	$106K	Sell	5,910 -8,350	-59%	-$146K	﹤0.01%	546
2024 Q2	$231K	Hold	14,260	–	–	0.01%	577
2024 Q1	$202K	Sell	14,260 -4,493	-24%	-$56.6K	0.01%	565
2023 Q4	$196K	Hold	18,753	–	–	0.01%	580
2023 Q3	$192K	Sell	18,753 -892	-5%	-$8.31K	0.01%	691
2023 Q2	$148K	Buy	19,645 +371	+2%	+$3.01K	0.01%	780
2023 Q1	$171K	Hold	19,274	–	–	0.01%	742
2022 Q4	$176K	Hold	19,274	–	–	0.01%	741
2022 Q3	$155K	Sell	19,274 -43	-0.2%	-$380	0.01%	788
2022 Q2	$146K	Buy	19,317 +200	+1%	+$1.74K	0.01%	824
2022 Q1	$180K	Buy	19,117 +690	+4%	+$5.76K	0.01%	816
2021 Q4	$148K	Hold	18,427	–	–	0.01%	889
2021 Q3	$180K	Buy	18,427 +10,227	+125%	+$95.8K	0.01%	831
2021 Q2	$81K	Hold	8,200	–	–	﹤0.01%	994
2021 Q1	$95K	Hold	8,200	–	–	﹤0.01%	918
2020 Q4	$79K	Hold	8,200	–	–	﹤0.01%	883
2020 Q3	$74K	Buy	+8,200	New	+$86.7K	﹤0.01%	870

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Banque Cantonale Vaudoise's TEVA Position: Q2 2026 in Review

Banque Cantonale Vaudoise reduced its Teva Pharmaceuticals (TEVA) stake by 29% in Q2 2026, selling an estimated $50.2K and leaving 3,627 shares worth $123. The position accounts for ﹤0.01% of the portfolio, ranked #688.

Banque Cantonale Vaudoise first reported a position in TEVA in Q3 2020 and has held it in 23 quarters since. The position peaked at $231K in Q2 2024. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Banque Cantonale Vaudoise held 3,627 shares of Teva Pharmaceuticals worth $123 as of Q2 2026.
Banque Cantonale Vaudoise sold 1,506 Teva Pharmaceuticals shares in Q2 2026, an estimated $50.2K.
Teva Pharmaceuticals made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #688 holding.
Banque Cantonale Vaudoise first reported a position in Teva Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
Banque Cantonale Vaudoise's Teva Pharmaceuticals position peaked at $231K in Q2 2024.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.